{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-222964","form_type":"8-K","ticker":"TSHA","cik":"0001806310","company_name":"Taysha Gene Therapies, Inc.","filed_at":"2023-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.332557+00:00","generated_at":"2026-06-11T02:28:03.497743+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Taysha Gene Therapies regains compliance with Nasdaq listing rules","bullets":["Received Nasdaq notice on Aug 28, 2023, confirming compliance with minimum Market Value of Listed Securities of $50M.","Received separate Nasdaq notice on same date confirming compliance with minimum bid price of $1.00 per share.","Both compliance matters are now closed, removing delisting risk for TSHA on Nasdaq Global Select Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-222964","json":"https://secwatch.observer/filing/0001193125-23-222964.json","markdown":"https://secwatch.observer/filing/0001193125-23-222964.md","text":"https://secwatch.observer/filing/0001193125-23-222964.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1806310/000119312523222964/0001193125-23-222964-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1806310/000119312523222964/d521077d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:28:03.497743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}